A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Clinical trial NCT06901531 · RECRUITING

Trial details

NCT number: NCT06901531
Sponsor: Astellas Pharma Global Development, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer Metastatic Gastric Adenocarcinoma or Cancer Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

Start date: 2025-05-22
Primary completion: 2027-03-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.